RxSight Inc (NAS:RXST)

Q3 2025 Rxsight Inc Earnings Call Transcript

Nov 5, 2025 / 09:30 PM GMT

Release Date Price: $8.34 (-7.33%)

Transcript 10-Q8-K

Key Points

Positve

RxSight Inc (RXST) reported a significant increase in gross margin to 79.9% in Q3 2025, up from 71.4% in the same period last year, driven by a higher mix of Light Adjustable Lens (LAL) sales.
The company has successfully expanded its LDD installed base by 25% year-over-year, reaching 1,109 units.
RxSight Inc (RXST) has launched new practice development and clinical engagement programs, such as the masterclass and Eleva programs, to enhance clinical confidence and optimize LAL workflow.
International expansion is progressing well, with regulatory access in Europe and Asia, and the appointment of an Executive Vice President of International to lead these efforts.
The company has narrowed its full-year revenue guidance to $125 million to $130 million, reflecting confidence in consistent LAL procedure trends and strategic LDD sales.

Negative

Q3 2025 revenue decreased by 14% year-over-year to $30.3 million, and by 10% compared to the previous quarter.
LDD sales saw a significant decline, with only 25 units sold in Q3 2025, down 68% from the prior year period.
The company reported a GAAP net loss of $9.8 million in Q3 2025, compared to a loss of $6.3 million in the same quarter of 2024.
Operating expenses are expected to increase by 7% to 14% over 2024, driven by personnel costs, stock-based compensation, and marketing expenses.
The reduction in Medicare's 2026 physician fee for cataract surgery by 11% may impact the financial dynamics for practices, potentially affecting LAL adoption.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RXST.OQ - Rxsight Inc
Q3 2025 Rxsight Inc Earnings Call
Nov 05, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello everyone.

Thank you for standing by. My name is and I'll be operator for today. At this time, I would like to welcome each and every one of you to the RX site 3rd quarter to a 25 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during that time, simply press car followed by the number one on a telephone keypad.

I will now send the call over to Mr. Oliver Mora Moravi, Vice President of Infra relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-----------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.